Back to catalog
Peptide Companion
single
Sexual Health
Vial: 10 mg

Melanotan II (10 mg Vial)

Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for inducing erectile activity as a side effect. Early human trials identified effective daily doses in the range of 1–2 mg for tanning, with conservative protocols starting lower to minimize side effects such as nausea and flushing. This educational protocol presents a once-daily subcutaneous titration approach using practical dilution for clear insulin-syringe measurements.

Dose
0.25–0.5 mg per injection
Frequency
3–7 times weekly
Timing
Any time of day
Duration
Until desired pigmentation achieved

Melanocortin receptor agonist. Promotes tanning. Start low to assess tolerance.

Dosing Schedule
Week / PhaseDaily DoseUnits (per injection) (mL)
Week 1250 mcg (0.25 mg)7.5 units (0.075 mL)
Week 2500 mcg (0.5 mg)15 units (0.15 mL)
Week 3750 mcg (0.75 mg)22.5 units (0.225 mL)
Weeks 4–81000 mcg (1 mg)30 units (0.30 mL)
Maintenance<br>(after Week 8)500–1000 mcg<br>(1–2× weekly)15–30 units<br>(0.15–0.30 mL)
Supplies Needed
  • •Peptide Vials (Melanotan II, 10 mg each):
  • •Insulin Syringes (U-100, 1 mL):
  • •Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References
  • PubMed — Dorr RT et al. (1996)

    Dorr RT et al. (1996)**

    View source
  • International Peptide Society — Melanotan II Monograph

    Melanotan II Monograph**

    View source
  • DermNet NZ — Melanotan II Information for Patients

    Melanotan II Information for Patients**

    View source
  • PubMed — Nelson ME et al. (2012)

    Nelson ME et al. (2012)**

    View source
  • RxList — Melanotan-II Uses, Side Effects and Dosing

    Melanotan-II Uses, Side Effects and Dosing**

    View source
  • Cell Sciences Inc. — Product Data Sheet

    Product Data Sheet**

    View source
  • MedlinePlus — Subcutaneous Injections

    Subcutaneous Injections**

    View source
  • NCBI Bookshelf — Administration of Parenteral Medications

    Administration of Parenteral Medications**

    View source
  • CDC — Vaccine Administration Guidelines

    Vaccine Administration Guidelines**

    View source
  • NCBI Bookshelf — Best Practices for Injection Safety

    Best Practices for Injection Safety**

    View source

Educational content adapted from peptidedosages.com. Not medical advice.